
### [NCIT:C94759](http://purl.obolibrary.org/obo/NCIT_C94759)
**Label:** Functioning Endocrine Neoplasm

**Subclasses:** [NCIT:C67369](http://purl.obolibrary.org/obo/NCIT_C67369) (Malignant Pancreatic Somatostatinoma), [NCIT:C27466](http://purl.obolibrary.org/obo/NCIT_C27466) (Pancreatic ACTH-Producing Neuroendocrine Tumor), [NCIT:C65187](http://purl.obolibrary.org/obo/NCIT_C65187) (Malignant Pancreatic Glucagonoma), [NCIT:C121720](http://purl.obolibrary.org/obo/NCIT_C121720) (Functioning Pituitary Gland Macroadenoma), [NCIT:C7047](http://purl.obolibrary.org/obo/NCIT_C7047) (Functioning Pituitary Gland Neoplasm), [NCIT:C95597](http://purl.obolibrary.org/obo/NCIT_C95597) (Pancreatic Glucagonoma), [NCIT:C121679](http://purl.obolibrary.org/obo/NCIT_C121679) (Functioning Pituitary Gland Microadenoma), [NCIT:C45841](http://purl.obolibrary.org/obo/NCIT_C45841) (Functional Pancreatic Neuroendocrine Tumor G2), [NCIT:C8388](http://purl.obolibrary.org/obo/NCIT_C8388) (Functioning Pituitary Gland Adenoma), [NCIT:C95595](http://purl.obolibrary.org/obo/NCIT_C95595) (Pancreatic Somatostatinoma), [NCIT:C45840](http://purl.obolibrary.org/obo/NCIT_C45840) (Functional Pancreatic Neuroendocrine Tumor), 

**Class expressions from DL-Learner:**

- [NCIT:C45981](http://purl.obolibrary.org/obo/NCIT_C45981) (Presence of a Hormonal Syndrome) 57.14%
- Thing 52.12%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39130](http://purl.obolibrary.org/obo/NCIT_C39130) (Insulin Signaling Pathway))) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39128](http://purl.obolibrary.org/obo/NCIT_C39128) (IL7 Signaling Pathway))) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39124](http://purl.obolibrary.org/obo/NCIT_C39124) (IL3 Signaling Pathway))) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39123](http://purl.obolibrary.org/obo/NCIT_C39123) (IL2RB Pathway))) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39121](http://purl.obolibrary.org/obo/NCIT_C39121) (IL22 Signaling Pathway))) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39117](http://purl.obolibrary.org/obo/NCIT_C39117) (IL12 Signaling Pathway))) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39114](http://purl.obolibrary.org/obo/NCIT_C39114) (IGF-1 Signaling Pathway))) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39112](http://purl.obolibrary.org/obo/NCIT_C39112) (IFN Gamma Signaling Pathway))) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39103](http://purl.obolibrary.org/obo/NCIT_C39103) (ERBB2 Signaling Pathway))) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39102](http://purl.obolibrary.org/obo/NCIT_C39102) (Skeletal Myogenesis Pathway))) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39101](http://purl.obolibrary.org/obo/NCIT_C39101) (Human Cytomegalovirus Infection Pathway))) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39094](http://purl.obolibrary.org/obo/NCIT_C39094) (Inhibition of Cellular Proliferation by Gleevec Pathway))) 42.50%


